Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly

Journal of Endocrinological Investigation

Volumn 26, Issue 2, 2003, Pages 123-127

  Grottoli, S ^a   Razzore, P ^a   Gaia, D ^a   Gasperi, M ^b   Giusti, M ^c   Colao, A ^d   Ciccarelli, E ^a   Gasco, V ^a   Martino, E ^b   Ghigo, E ^a   Camanni, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Acromegaly; Diagnosis; Glucose

Indexed keywords

GLUCOSE; GROWTH HORMONE; SODIUM CHLORIDE;

ACROMEGALY; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HUMAN; HYPOPHYSIS TUMOR; INFUSION; MAJOR CLINICAL STUDY; MALE; MINIMAL RESIDUAL DISEASE; NEUROSURGERY; ORAL GLUCOSE TOLERANCE TEST; RELIABILITY;

EID: 0037318236     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345139     Document Type: Article

References (31)

1. Daughaday W.H., Starkey R.H., Saltman S., Gavin G.R. III, Mills-Dunlap B., Health-Monning E. Characterization of serum growth-hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH. J. Clin. Endocrinol. Metab. 1987, 65: 617-623.
2. Hoffenberg R., Howell A., Epstein S. et al. Increasing growth with raise circulating somatomedin but normal immunoassayable growth hormone. Clin. Endocrinol. 1977, 6: 443-448.
3. Mims R.B., Bethune J.E. Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation. Ann. Intern. Med. 1974, 81: 781-784.
4. Melmed S., Ho K., Klibanski A., Reichlin S., Thorner M. Recents advances in pathogenesis, diagnosis and management of acromegaly. J. Clin. Endocrinol. Metab. 1995, 80: 3395-3402.
5. Giustina A., Barkan A., Casanueva F.F. et al. Criteria for cure of acromegaly: A consensus statement. J. Clin. Endocrinol. Metab. 2000, 85: 526-529.
6. Clemmons D.R., Van Wyck J.J., Ridgway E.D.C., Kliman B., Kjellberg R.N., Underwood L.E. Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N. Engl. J. Med. 1979, 301: 1138-1142.
7. Barkan A.L., Beitins I.Z., Kelch R.P. Plasma insulin-like growth factor-I/somatodedin-C in acromegaly: Correlation with the degree of growth hormone hypersecretion. J. Clin. Endocrinol. Metab. 1988, 67: 69-73.
8. Ho K.K.Y., Weissberg A.J. Characterization of 24-hour growth hormone secretion in acromegaly: Implications for diagnosis and therapy. Clin. Endocrinol. 1994, 41: 75-83.
9. Rieu M., Girard F., Bricare H., Binoux M. The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegally. J. Clin. Endocrinol. Metab. 1982, 55: 147-153.
10. Stoffel-Wagner B., Springer W., Bidlingmaier F., Klingmuller D. A comparison of different methods for diagnosing acromegaly. Clin. Endocrinol. 1997, 46: 531-537.
11. Jasper H., Pennisi P., Vitale M., Mella A., Ropelato G., Chervin A. Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score. J. Endocrinol. Invest. 1999, 22: 29-34.
12. Smith W.J., Underwood L.E., Clemmons D.R. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J. Clin. Endocrinol. Metab. 1995, 80: 443-449.
13. Thissen J.P., Ketelslegers J.M., Underwood L.E. Nutritional regulation of the insulin-like growth factors. Endocrine. Rev. 1994, 15: 80-101.
14. Hall K., Hilding A., Thoren M. Determinants of circulating insulin-like growth factor-I. J. Endocrinol. Invest. 1999, 22: 48-57.
15. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging. Endocrine Rev. 1993, 14: 20-39.
16. Ghigo E., Aimaretti G., Gianotti L., Bellone J., Arvat E., Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 1996, 134: 352-356.
17. Duncan E., Wass J.A.H. Investigation protocol: Acromegaly and its investigation. Clin. Endocrinol. 1999, 50: 285-293.
18. Earll J.M., Sparks L.L., Forsham P.H. Glucose suppression of serum growth hormone in the diagnosis of acromegaly. J. Am. Med. Ass. 1967, 201: 134-136.
19. Chapman I.M., Hartman M.L., Straume M., Johnson M.L., Veldhuis J.D., Thorner M.O. Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than in women. J. Clin. Endocrinol. Metab. 1994, 78: 1312-1319.
20. Colao A., Lombardi G. Growth-hormone and prolactin excess. Lancet 1998; 352: 1455-146.
21. Grecu E.O., Walter R.M., Gold E.M. Paradoxical release of growth hormone during oral glucose tolerance test in patients with abnormal glucose tolerance. Metabolism 1983, 32: 134-137.
22. Becker M.D., Cook G.C., Wright A.D. Paradoxical elevation of growth hormone in active chronic hepatitis. Lancet 1969, 2: 1035-1039.
23. Tamai H., Kiyohara K., Mukuta Y. et al. Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosa. Metabolism 1991, 40: 31-34.
24. Maccario M., Procopio M., Grottoli S. et al. In obesity the somatotrope response to either GHRH or arginine is inhibited by somatostatin or pirenzepine but not by glucose. J. Clin. Endocrinol. Metab. 1995, 80: 3774-3778.
25. Grottoli S., Maccario M., Procopio M. et al. The somatotrope responsiveness to hexarelin, synthetic hexapeptidde, is refractory to the inhibitory effect of glucose in obesity. Eur. J. Endocrinol. 1995, 135: 678-682.
26. Semer M., Faria A.C.S., Nery M. et al. Growth hormone pulsatility in active and cured acromegalic subjects. J. Clin. Endocrinol. Metab. 1995, 80: 3767-3770.
27. Iranmanesh A., Grisso B., Velduis J.D. Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatropic men studied with a new ultrasensitive chemiluminescence assay. J. Clin. Endocrinol. Metab. 1994, 78: 526-535.
28. Melmed S., Jackson I., Klienberg D., Klibanski A. Current treatment guidelines for acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 2646-2652.
29. Hattori N., Shimatsu A., Kato Y. et al. Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly. J. Clin. Endocrinol. Metab. 1990, 70: 771-776.
30. Wass J.A.H. Growth hormone, insulin-like growth factor-I and its binding proteins in follow-up of acromegaly. J. Endocrinol. 1997, 155: S17-S19.
31. Freda P.U., Kalmon D.P., Jefrey S.P., Sharon L.W. Evaluation of the disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly. J. Clin. Endocrinol. Metab. 1998, 83: 3808-3816.